Objectives: To investigate the efficacy of the chronic usage of the cholinesterase inhibitor rivastigmine in patients with dementia in the prevention of delirium in case of hospitalisation.
Design: Retrospective cohort study.
Setting: Non-geriatric wards of an 1120 bed general teaching hospital in s-Hertogenbosch, The Netherlands.